Netcare Pholoso Hospital achieves Level II trauma centre accreditation
Drickus Maartens • June 22, 2020
(Left to right): Registered nurse, Sr Winnie Sebat; head of Netcare Pholoso Hospital’s trauma programme and lead general surgeon Dr Nelson Latakgomo; enrolled nurse auxiliary, Delina Legodi; enrolled nurse, Anna Machaka; and anaesthetist, Dr Sylvia Dlamini are pictured in the trauma theatre of the emergency department of Netcare Pholoso Hospital. The hospital is Limpopo’s first Level II trauma centre to be accredited by the Trauma Society of South Africa.
TSSA certification an important development for emergency medicine in Limpopo
The Trauma Society of South Africa (TSSA)
has accredited Netcare Pholoso Hospital
as a Level II trauma centre, certifying that the necessary professional medical services are available at the facility to deal with trauma cases and medical emergencies in line with international best practice in trauma medicine.
Mande Toubkin, Netcare’s general manager: emergency, trauma, transplant and CSI, says that the hospital is the first TSSA-accredited trauma centre in Limpopo province.
“Netcare Pholoso Hospital, which opened in September 2015, has in a relatively short time established a reputation among the communities of Polokwane and further afield, as a trusted private healthcare provider, and this will be further cemented with the hospital’s trauma accreditation,” she says.
“Accreditation processes, such as those employed by the TSSA to benchmark trauma centres within South Africa, have been shown internationally to encourage best practice, patient advocacy, patient safety and improved clinical outcomes. This contributes to the strengthening of provincial and national systems of trauma treatment, which ultimately benefits the communities served by accredited trauma facilities such as Netcare Pholoso Hospital.”
Head of Netcare Pholoso Hospital’s trauma programme, general surgeon Dr Nelson Latakgomo, says that the TSSA accreditation is the culmination of a long process and considerable hard work by doctors, management, nurses and support staff at the hospital.
“The high standards and the rigorous processes that the TSSA sets for accredited trauma centres to implement to ensure that trauma protocols are followed fully, provide assurance to the public that Netcare Pholoso Hospital is equipped to handle complex medical emergencies, including life-threatening injuries to adults and children. We are committed to maintaining these standards consistently into the future, as they are monitored by the TSSA on an ongoing basis.”
Dr Latakgomo notes that in the past, Limpopo residents who sustained critical or ‘P1’ injuries in the province were, in many cases, airlifted to Netcare Milpark Hospital in Johannesburg because of that facility’s Level I trauma centre status.
“Now that Netcare Pholoso Hospital is accredited as a Level II trauma centre, such patients can now be effectively treated much nearer their homes and families. The only difference between a Level I and Level II TSSA accreditation is the requirement for Level I trauma centres to have community education trauma prevention programmes in place.
“Not only does Netcare Pholoso Hospital’s Level II accreditation have cost-saving implications for individuals, families and healthcare funders alike, it also means that, crucially, if a person is injured here in Limpopo the transit time to our accredited trauma centre is potentially significantly reduced, which can improve a person’s clinical outcome. We are therefore pleased to bring this level of care to our communities’ doorstep,” Dr Latakgomo says.
The emergency department unit manager at Netcare Pholoso Hospital, Simon Shayi, who has 14 years’ experience in the field of emergency medicine, says where necessary, specialists from different disciplines within the hospital consult on trauma cases.
“This capacity to provide round-the-clock multi-disciplinary care is an essential aspect of Level II trauma centres, and it is reassuring for the public to know that we are able to treat high priority and potentially life-threatening emergencies, including polytrauma cases, in a coordinated and effective manner.
“As part of the accreditation process, the emergency department doctors and other specialists, nursing and intensive care unit staff members are required to follow trauma protocols,” Shayi explains.
The emergency department at Netcare Pholoso Hospital incorporates five private examination bays, three resuscitation bays with X-ray equipment on hand in the resuscitation area, a separate room for treating children, as well as a Netcare sexual assault centre for survivors of sexual assault. There is also a landing pad on the hospital premises for patients brought in by helicopter air ambulance.
The general manager of Netcare Pholoso Hospital, Fabion Bennet, welcomed the accreditation and expressed thanks to the TSSA as well as to the doctors, hospital staff and others within Netcare who contributed to its attainment.
“Dr Latakgomo and his team, as well as Simon Shayi, deserve special recognition for their efforts towards this milestone in our hospital’s history, which is also an important development for healthcare in the province,” Bennet says.
“We have been working towards achieving this goal since April 2018, and our sincere appreciation goes to the national Netcare trauma team under the leadership of Mande Toubkin for their robust support throughout the accreditation process,” he concluded.
Netcare Pholoso Hospital is the first facility in Limpopo province to be accredited by the Trauma Society of South Africa (TSSA). The hospital achieved accreditation as a Level II trauma centre, and is equipped to treat high priority and potentially life-threatening emergencies, including polytrauma cases. In a simulated resuscitation, trauma-trained registered Nurse Brian Masahaba (left) and lead emergency department doctor, Dr Rhulani Khosa (centre), assisted by the emergency department unit manager, Simon Shayi, show how a patient would be attended to in the state of the art trauma resuscitation section of the emergency department.
Netcare hospitals that are accredited by the Trauma Society of South Africa:
KwaZulu-Natal
- Netcare St Anne’s Hospital – Level I
- Netcare St Augustine’s Hospital – Level II
- Netcare uMhlanga Hospital – Level II
- Netcare Alberlito Hospital – Level III
- Netcare Kingsway Hospital – Level III
Western Cape
- Netcare Blaauwberg Hospital – Level III
- Netcare Kuilsriver Hospital – Level III
Limpopo
- Netcare Pholoso Hospital – Level II
Gauteng
- Netcare Milpark Hospital – Level I
- Netcare Union Hospital – Level I
- Netcare Sunninghill Hospital – Level II
- Netcare Garden City Hospital – Level II
- Netcare Unitas Hospital – Level II
- Netcare Linksfield Hospital – Level III
- Netcare Olivedale Hospital – Level III
- Netcare Waterfall City Hospital – Level III
- Netcare Krugersdorp Hospital – Level III
- Netcare Pinehaven Hospital – Level III
- Netcare Pretoria East Hospital – Level III
- Netcare Montana Hospital – Level III
Dr Michael de Villiers explains why people can become sick every flu season and why the influenza vaccine is generally recommended every year.
Colorectal cancer, one of the most prevalent yet preventable cancers, can develop in the colon or rectum, often starting as small polyps that can quietly become malignant if left unchecked. Dr Mpho Ramabulana, a colorectal surgeon and gastroenterologist at Netcare Akasia Hospital, underscores the life-saving power of vigilance and the importance of early detection.
Cardiologist Dr Robert Routier urges the public to check their personal risk factors regularly to help prevent or manage cardiovascular disease.
The physical strain pregnancy puts on an expectant mother’s body should not be underestimated. An obstetrician gynaecologist offers her insights for alleviating discomfort and promoting wellbeing with exercise and stretching throughout pregnancy.
Dr Patience Sigwadi, a leading paediatric nephrologist practising at Netcare Unitas Hospital in Centurion, has issued an urgent call for increased focus on skills development to address the escalating kidney disease crisis among children in South Africa.
Paediatric Nephrologist Professor Bhimma was recently awarded the Fellowship to acknowledge his extensive work in research, community-based outreach and teaching of paediatric nephrology, among others.
Netcare congratulates Professor Bhekifa Dube on his invitation to join the European Society for Vascular Surgery's clinical practice guidelines committee. His selection as the only specialist from the continent highlights the significance of this achievement on the global stage.
The lives of millions of South Africans with a litany of rare diseases can be vastly improved, and even saved, by addressing challenges in identifying, studying and treating their conditions. With Rare Disease Day on the 28th of February 2025, the Rare Diseases Access Initiative (RDAI) is driving an evolution of the country’s healthcare, through innovative strategies to better care for over 4.2million people living with an estimated 7000 rare diseases. “As our healthcare system faces significant changes in the years ahead, it is vital that we also advocate for people living with rare diseases in South Africa, especially those with limited healthcare access,” said Kelly du Plessis, CEO of Rare Diseases South Africa (RDSA), a member of RDAI. “As part of our ongoing research and awareness efforts, RDAI has conducted an initial analysis of the incidence and prevalence of rare diseases within the country.” This research will assist in improving access to healthcare, policy development, and patient advocacy, while giving critical insight into the challenges faced by patients. “According to research, some rare diseases affect fewer than 1 in a million people, while others, such as Down syndrome, cystic fibrosis, and haemophilia, have a more recognisable prevalence,” says Dr. Helen Malherbe, RDAI lead researcher on rare disease prevalence data. “Many conditions are undetected, underdiagnosed or misdiagnosed, with too many having no information available about them at all.” The RDAI was formed in 2019 to promote a more favourable environment for those impacted by rare diseases in South Africa. Participants include Ampath, the Board of Healthcare Funders (BHF), Discovery Health, Genetic Counsellors South Africa (SASHG), the Government Employees Medical Scheme (GEMS), Health Funders Association (HFA), Medihelp, Medscheme, North-West University (NWU), Rare Diseases South Africa (RDSA), the South African Medical Association (SAMA) and The South African Medical Technology Industry Association (SAMED). The Council for Medical Schemes (CMS) participates as an observer. In the same year, Rare Disease International signed a memorandum of understanding with the World Health Organisation leading to an international rare disease policy framework. In 2021, the United Nations General Assembly moved to adopt a resolution recognising 300 million people living with rare diseases worldwide. “A general lack of awareness and delayed diagnosis remain major hurdles for those affected by rare diseases. Policymakers and healthcare stakeholders need to prioritise access to treatment, diagnosis, and support for rare disease patients,” says Bada Pharasi, CEO of IPASA, “Through this initiative, working collaboratively with stakeholders at every level of the healthcare supply chain, we can bring real and meaningful change to those affected, including family members and care givers, through smart and efficient strategies.” The globally agreed definition of a rare disease is any medical condition with a specific pattern of clinical signs, symptoms, and findings that affects fewer than or equal to 1 in 2000 persons in a population. “Most are genetic, and some are inherited and passed down in families,” Malherbe says. “Some affect only the patient’s genetic recipe, while others may be acquired during life due to infection, trauma, or environmental effects. For many, the cause is still unknown. “These conditions mainly affect children, as they are largely incurable and many are life-threatening. Some require specialised and co-ordinated care, some have limited and expensive treatment options, while others have no information or effective treatments at all,” she adds. The RDAI is calling for a patient-centred care model built on equitable access, transparency and efficiency. Naturally, this model calls for the open participation of patients, the healthcare industry, health professionals, and the Government. “The most critical elements are robust diagnosis standards, improved access to treatment, data collection and management, co-ordination of care, measurement of outcomes and ongoing collaborative research,” du Plessis says. “We need to establish rare disease advisory committees, map gaps and opportunities, establish system requirements, create a roadmap and plan a phased implementation with clear timelines.” The RDAI states that these policy development steps would be a start in quantifying the disease burden and defining standards of care. This would be followed by building and strengthening the capacity to facilitate appropriate diagnosis, treatment, continuity and data monitoring. Thoneshan Naidoo, Chief Executive Officer of the Health Funders Association noted that, “We appreciate the unique opportunity provided by RDAI which enables stakeholders across the industry to work together and identify strategies that improve equitable access to the appropriate diagnosis, treatment and healthcare services for rare disease patients, in an affordable and sustainable manner, taking account of the other pressing needs across the healthcare system.” “True innovation in healthcare is only possible through partnerships and joint advocacy efforts that raise awareness and improve access to treatment. Our long-term goal is the development of a rare diseases policy framework and guidelines for coordinated care,” says Pharasi. “Our members are united in the commitment to unlocking improved patient outcomes and improving access to services and robust health needs assessment facilities.” he concludes. About RDAI The Rare Diseases Access Initiative (RDAI) is dedicated to advocating for improved healthcare access, policy development, and patient support for those affected by rare diseases in South Africa. The initiative brings together key healthcare stakeholders, including pharmaceutical associations, funders, genetic specialists, and patient advocacy groups, to drive impactful change. About RDSA Founded in 2013, Rare Diseases South Africa (RDSA) is a non-profit organisation advocating to ensure that people living with rare diseases and congenital disorders experience greater recognition, support, improved health service and better overall quality of life. Started out of personal need following the diagnosis of organisation founder, Kelly du Plessis' son, it became evident that there was a lack of awareness and support for rare diseases in general in South Africa. About IPASA The Innovative Pharmaceutical Association South Africa (IPASA) is a voluntary trade association representing 24 leading pharmaceutical companies committed to research, development, and innovation. Our mission is to drive healthcare advancement by advocating for policies that improve patient access to safe, high-quality, and affordable medicines.
Gastroenterologist Dr. Barbara Makumbi discusses common risk factors and offers tips for managing reflux and the longer-term condition known as gastroesophageal reflux disease (GORD).
From treating trauma injuries caused by wildlife, road accidents and sports, to heart attacks, stroke, or the sudden onset of other concerning medical symptoms – the emergency department at Netcare St Anne’s Hospital never sleeps.
